Effects of Suramin on Breast Cancer Cells
Author Information
Author(s): J.A. Foekens, A.M. Sieuwerts, E.M.J. Stuurman-Smeets, H.A. Peters, J.G.M. Klijn
Primary Institution: Dr Daniel den Hoed Cancer Center
Hypothesis
How does suramin affect the cell cycle of MCF-7 human breast cancer cells in vitro?
Conclusion
Suramin inhibits the proliferation of MCF-7 breast cancer cells and causes them to accumulate in the G2/M phase of the cell cycle.
Supporting Evidence
- Suramin significantly inhibited cell proliferation at concentrations above 100 µg/ml.
- Prolonged exposure to suramin caused an accumulation of cells in the G2/M phase.
- Suramin's effects were observed under both serum-containing and serum-free conditions.
Takeaway
Suramin is a substance that can stop breast cancer cells from growing and makes them stay in a specific part of their life cycle.
Methodology
The study used cell proliferation assays and flow cytometry to assess the effects of suramin on MCF-7 cells.
Limitations
The study does not clarify whether the accumulation of cells in the G2/M phase is due to selective killing of other phases.
Participant Demographics
MCF-7 human breast cancer cells were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website